Healthcare3 min reading time

Rivercell raises $25M to build an AI model of how cells respond to drugs

The Next Web
Read the full article
Rivercell, a Paris-based startup, raised $25M to develop an AI model simulating how human cells respond to drugs and genetic changes by generating its own experimental data. The company aims to create a comprehensive 'world model' of the cell to improve medical understanding and reduce physical lab experiments.

More in Healthcare

Healthcare2 min read

Google launches $180 Fitbit Edge with a bigger screen and AI coach

The Next Web
Healthcare5 min read

As US medical debt grows, AI will be used more to collect it

The Guardian
Healthcare5 min read

Healthcare AI's Pilot-To-Production Problem

Forbes